| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017PLoSO..1280513H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0180513 |
| P932 | PMC publication ID | 5500352 |
| P698 | PubMed publication ID | 28683134 |
| P50 | author | Zhonglin Han | Q96030938 |
| P2093 | author name string | Wei Xu | |
| Biao Xu | |||
| Xiaohong Li | |||
| Xinlin Zhang | |||
| Zheng Chen | |||
| Hongsong Yu | |||
| Rongfang Lan | |||
| Wencheng Di | |||
| Wenqing Ji | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q21092360 |
| Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis | Q26751460 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events | Q28080520 | ||
| Epidemiology, diagnosis, and management of atrial fibrillation in women | Q28083655 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry | Q30594176 | ||
| Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data | Q30840555 | ||
| Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials | Q34196279 | ||
| Estrogen receptor-beta prevents cardiac fibrosis | Q34220113 | ||
| The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| Cardiac resynchronization in chronic heart failure | Q34524008 | ||
| Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach | Q34815160 | ||
| EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors. | Q35035181 | ||
| Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study | Q35085711 | ||
| The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study. | Q35335608 | ||
| Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients | Q35877589 | ||
| Sex differences in primary hypertension | Q35903054 | ||
| Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy | Q37073001 | ||
| Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy | Q37611691 | ||
| More favorable response to cardiac resynchronization therapy in women than in men. | Q38242112 | ||
| Interlead anatomic and electrical distance predict outcome in CRT patients | Q38411122 | ||
| Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Comb | Q38467278 | ||
| Toward Sex-Specific Guidelines for Cardiac Resynchronization Therapy? | Q38667272 | ||
| Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy | Q39604641 | ||
| Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization Therapy | Q39707648 | ||
| Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator | Q40014013 | ||
| Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy. | Q40575273 | ||
| Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure. | Q40908124 | ||
| Association of hypothyroidism with adverse events in patients with heart failure receiving cardiac resynchronization therapy | Q41287567 | ||
| Mechanical Dyssynchrony by Tissue Doppler Cross-Correlation is Associated with Risk for Complex Ventricular Arrhythmias after Cardiac Resynchronization Therapy | Q41404515 | ||
| Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy | Q41710879 | ||
| Outcome after implantation of cardiac resynchronization/defibrillation systems in patients with congestive heart failure and left bundle-branch block | Q43267647 | ||
| Female gender is associated with a better outcome after cardiac resynchronization therapy | Q43412348 | ||
| Left ventricular reverse remodeling, device-related adverse events, and long-term outcome after cardiac resynchronization therapy in the elderly | Q43552491 | ||
| Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience. | Q43708982 | ||
| Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. | Q43882609 | ||
| Women have better long-term prognosis than men after cardiac resynchronization therapy. | Q44159690 | ||
| Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial | Q44669327 | ||
| Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial | Q44835795 | ||
| Women with nonischemic cardiomyopathy have a favorable prognosis and a better left ventricular remodeling than men after cardiac resynchronization therapy | Q44979222 | ||
| The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. | Q45900972 | ||
| The European CRT Survey: 1 year (9-15 months) follow-up results. | Q46029893 | ||
| Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. | Q46068881 | ||
| The impact of left ventricular size on response to cardiac resynchronization therapy | Q47350793 | ||
| Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors | Q47449189 | ||
| Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation | Q47676160 | ||
| Gender disparity in the use of cardiac resynchronization therapy in the United States | Q47810295 | ||
| Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy | Q47893061 | ||
| Gender-related safety and efficacy of cardiac resynchronization therapy | Q48155854 | ||
| Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. | Q50690756 | ||
| Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. | Q51083978 | ||
| Cardiac resynchronization therapy: do women benefit more than men? | Q51414261 | ||
| Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy. | Q51470064 | ||
| Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. | Q51729649 | ||
| Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. | Q51768133 | ||
| Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy. | Q53134319 | ||
| Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score. | Q53255168 | ||
| Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function. | Q53584406 | ||
| Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. | Q55041198 | ||
| Impaired Renal Function Is Associated With Echocardiographic Nonresponse and Poor Prognosis After Cardiac Resynchronization Therapy | Q57299447 | ||
| Differentiating Electromechanical From Non–Electrical Substrates of Mechanical Discoordination to Identify Responders to Cardiac Resynchronization Therapy | Q61913850 | ||
| Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults | Q73562394 | ||
| Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure | Q80453743 | ||
| The impact of age and gender on cardiac resynchronization therapy outcome | Q81537249 | ||
| Very long term follow-up of cardiac resynchronization therapy: clinical outcome and predictors of mortality | Q81625537 | ||
| Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) | Q82214544 | ||
| Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy | Q82314879 | ||
| Renal function and mortality following cardiac resynchronization therapy | Q82414338 | ||
| Long-term outcomes of CRT-PM versus CRT-D recipients | Q83402752 | ||
| Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy | Q83433276 | ||
| Incremental prognostic value of combining left ventricular lead position and systolic dyssynchrony in predicting long-term survival after cardiac resynchronization therapy | Q83589296 | ||
| Left ventricular lead position and nonspecific conduction delay are predictors of mortality in patients during cardiac resynchronization therapy | Q83913462 | ||
| Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy | Q84178540 | ||
| Impact of left atrial volume in prediction of outcome after cardiac resynchronization therapy | Q84558102 | ||
| Baseline delayed left ventricular activation predicts long-term clinical outcome in cardiac resynchronization therapy recipients | Q84967529 | ||
| Cardiac-specific sympathetic activation in men and women with and without heart failure | Q85104024 | ||
| CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy | Q87048859 | ||
| Patient-assessed short-term positive response to cardiac resynchronization therapy is an independent predictor of long-term mortality | Q87556709 | ||
| The Miracle of Microfinance? Evidence from a Randomized Evaluation | Q105838393 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0180513 | |
| P577 | publication date | 2017-07-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Sex-specific mortality differences in heart failure patients with ischemia receiving cardiac resynchronization therapy | |
| P478 | volume | 12 |
Search more.